BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23755052)

  • 1. Regulation of adaptive immunity; the role of interleukin-10.
    Ng TH; Britton GJ; Hill EV; Verhagen J; Burton BR; Wraith DC
    Front Immunol; 2013; 4():129. PubMed ID: 23755052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the IL-9 pathway in cancer immunotherapy.
    Zheng N; Lu Y
    Hum Vaccin Immunother; 2020 Oct; 16(10):2333-2340. PubMed ID: 32040369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 as Innate Mediator of T Cell Immunity.
    Van Den Eeckhout B; Tavernier J; Gerlo S
    Front Immunol; 2020; 11():621931. PubMed ID: 33584721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T Helper Cell Subsets and Related Human Immunological Disorders.
    Zhu X; Zhu J
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy.
    Yang Y; Lundqvist A
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.
    Liao W; Lin JX; Leonard WJ
    Immunity; 2013 Jan; 38(1):13-25. PubMed ID: 23352221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Natural Killer Cells in Autoimmune Diseases.
    Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
    Front Immunol; 2021; 12():622306. PubMed ID: 33717125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
    Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.
    Liu B; Tonkonogy SL; Sartor RB
    Gastroenterology; 2011 Aug; 141(2):653-62, 662.e1-4. PubMed ID: 21679711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.
    Anderson CF; Oukka M; Kuchroo VJ; Sacks D
    J Exp Med; 2007 Feb; 204(2):285-97. PubMed ID: 17283207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review.
    Bao Y; Cao X
    J Autoimmun; 2014 Dec; 55():10-23. PubMed ID: 24794622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate IL-17-producing cells: the sentinels of the immune system.
    Cua DJ; Tato CM
    Nat Rev Immunol; 2010 Jul; 10(7):479-89. PubMed ID: 20559326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.
    Imamichi H; Sereti I; Lane HC
    Eur J Immunol; 2008 Jun; 38(6):1621-30. PubMed ID: 18493981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of interleukin-10-mediated immune suppression.
    Akdis CA; Blaser K
    Immunology; 2001 Jun; 103(2):131-6. PubMed ID: 11412299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
    Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
    Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.